Treatment and 4-Year Follow-Up of 163 Stanford Type B Aortic Dissections: A Single-Center Experience

Xin Li,Chang Shu
DOI: https://doi.org/10.1016/j.jvs.2012.11.023
IF: 4.86
2013-01-01
Journal of Vascular Surgery
Abstract:Endovascular treatment of Stanford type B aortic dissection is becoming more prevalent. This study analyzed the data of patients in our department with this type of dissection, and compared the results of endovascular treatment vs medical treatment. Between January 2005 and April 2009, 163 patients with the diagnosis of Stanford type B dissection were studied. Mean age was 52.71 ± 11.46 years. All patients were treated with antihypertension drugs when admitted. The indication for routine endovascular repair was progressive blood flow into a false lumen. Indications for emergency endovascular repair were impending rupture, uncontrollable hypertension, malperfusion syndrome, and intractable pain. Patients were followed up after discharge. Total mortality was 9.82% (16 of 163). Ninety-three patients were treated by endovascular repair, and 70 were treated conservatively. The longest follow-up time was 50 months. Kaplan-Meier curve was used to compare the survival rate of the two groups. Log-rank test showed that the survival rate of the endovascular repair group was higher than in the conservative treatment group (P = .004). Cox regression was used to demonstrate the most significant factors related to risk of death. Patients with conservative treatment (P = .005) along with lower oxygen saturation in the blood (P = .0004) had higher mortality. In short to medium follow-up, the survival rate of endovascular repair to Stanford type B dissection is higher than medical treatment.
What problem does this paper attempt to address?